The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine

類似資料

• The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine.
  著者:: Xiaorui Chen, 等
  出版事項: (2024-06-01)
• Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants
  著者:: Wei-Shuo Lin, 等
  出版事項: (2021-12-01)
• Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
  著者:: Ching-Wen Hou, 等
  出版事項: (2025-01-01)
• A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2
  著者:: Shixia Wang, 等
  出版事項: (2022-12-01)
• An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
  著者:: Xiaojing Chi, 等
  出版事項: (2022-02-01)